Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy

Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy

Abstract Background Panax notoginseng triol saponins (PTS) has been used clinically for ischemic stroke therapy (IST) in China for more than 17 years due to its anti-platelet aggregation and neuro-protective effects, but its mechanism of action is not fully understand. In this study, anti-platelet a...

Full description

Bibliographic Details
Main Authors: Zhi-yi Xu, Yang Xu, Xiao-fang Xie, Yin Tian, Jun-hui Sui, Yong Sun, Da-sheng Lin, Xing Gao, Cheng Peng, Yu-jiang Fan
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Chinese Medicine
Subjects:
PTS
Anti-platelet aggregation
GP1BA
Binding affinity
Ischemic stroke
Online Access:https://doi.org/10.1186/s13020-021-00424-3

Internet

https://doi.org/10.1186/s13020-021-00424-3

Similar Items